版本:
中国

BRIEF-HTG Molecular Diagnostics says ‍entered amended and restated development and component supply agreement with illumina

June 2 HTG Molecular Diagnostics Inc:

* HTG Molecular Diagnostics - ‍entered amended and restated development and component supply agreement with illumina, inc effective may 31 - sec filing​

* HTG Molecular Diagnostics - ‍co required to pay illumina up to $0.6 million upon achievement of specified regulatory milestones relating to ivd test kits​

* HTG Molecular Diagnostics- agreed to pay illumina single digit percent royalty on net sales of ivd test kits co commercializes pursuant to restated deal ‍​

* HTG Molecular-‍filed amendment to prospectus supplement to increase amount of stock that may be offered in atm offering under sales deal to $40 million Source text - bit.ly/2rB1ciX Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐